A Study of IBI306 in Participants With Hypercholesterolemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 306 participants.
Also called NCT04709536
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 306 participants
- Registry
-
NCT04709536
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04709536. Randomized; triple masking; primary purpose treatment. Start 2021-02-09 (actual); primary completion 2021-11-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of IBI306 in Participants With Hypercholesterolemia
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- IBI306
- Intervention (Drug)
- Placebo
- Lead sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
Record details
- Record id
cardio:ct-nct04709536- Content hash
32a673d7b89c25b1ebcd6181dfeaf4e6f8ebaa4c7d90297eff43a04595bf14d5